Castle Biosciences Inc. (CSTL)

NASDAQ: CSTL · Real-Time Price · USD

19.85

-0.24 (-1.19%)

At close: Apr 29, 2025, 3:59 PM

19.85

0.00%

After-hours: Apr 29, 2025, 04:05 PM EDT

Castle Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	119.71M	98.84M	122.95M	329.63M	409.85M	98.84M	4.48M	1.21M
Short-Term Investments	173.42M	144.26M	135.68M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	1.09M	1.31M	1.1M	870K	2.53M	1.56M
Other Long-Term Assets	2.15M	2.63M	-25.58M	3.02M	1.54M	135K	2.75M	1.63M
Receivables	51.22M	38.3M	23.48M	17.28M	12.76M	14.65M	12.09M	4.65M
Inventory	8.13M	7.94M	3.98M	2.02M	2.22M	1.24M	882.23K	304.58K
Other Current Assets	7.67M	6.29M	6.21M	4.81M	4.77M	1.95M	n/a	n/a
Total Current Assets	360.15M	295.63M	292.29M	353.74M	429.59M	116.68M	18.13M	6.68M
Property-Plant & Equipment	62.71M	37.74M	26.5M	16.88M	7.1M	2.06M	1.53M	1.47M
Goodwill & Intangibles	106.23M	117.33M	126.35M	88.92M	n/a	n/a	4.17K	40.12K
Total Long-Term Assets	171.08M	157.71M	155.04M	108.83M	9.73M	3.06M	4.28M	3.14M
Total Assets	531.24M	453.34M	447.33M	462.57M	439.33M	119.75M	22.4M	9.82M
Account Payables	6.9M	10.27M	4.73M	2.55M	2.1M	1.86M	1.45M	1.12M
Deferred Revenue	n/a	n/a	n/a	n/a	6.62M	n/a	n/a	9.73K
Short-Term Debt	1.94M	n/a	1.78M	1.18M	n/a	5.83M	n/a	1M
Other Current Liabilities	35.63M	30.69M	23.9M	15.73M	2.18M	79K	706.64K	n/a
Total Current Liabilities	49.39M	47.67M	36.13M	24.89M	20.88M	15.29M	6.74M	5.22M
Long-Term Debt	24.4M	n/a	n/a	n/a	n/a	19.29M	24.5M	17.6M
Other Long-Term Liabilities	n/a	n/a	90K	18.41M	1.03M	55K	1.24M	1.27M
Total Long-Term Liabilities	26.01M	14.4M	12.05M	25.95M	2.76M	19.34M	25.74M	18.87M
Total Liabilities	75.4M	62.07M	48.18M	50.83M	23.64M	34.63M	32.47M	24.09M
Total Debt	26.34M	15.34M	13.31M	8.08M	n/a	25.12M	24.5M	18.6M
Common Stock	28K	27K	27K	25K	25K	17K	1.92K	1.9K
Retained Earnings	-200.13M	-218.37M	-160.91M	-93.77M	-62.5M	-52.21M	-57.49M	-51.12M
Comprehensive Income	230K	136K	-381K	n/a	0.00	-119.75M	-909.38K	-638.47K
Shareholders Equity	455.83M	391.27M	399.15M	411.74M	415.69M	85.11M	-10.07M	-14.27M
Total Investments	173.42M	144.26M	135.68M	1.31M	1.1M	870K	2.53M	1.56M